These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2505873)

  • 1. Interaction between diazepam and oral antidiabetic agents on serum glucose, insulin and chromium levels in rats.
    al-Ahmed FA; el-Denshary ES; Zaki M; el-Sawaf HA; Abu-Jayyab AR
    Biosci Rep; 1989 Jun; 9(3):347-50. PubMed ID: 2505873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists.
    Abdel-Zaher AO; Ahmed IT; El-Koussi AD
    Pharmacol Res; 2001 Nov; 44(5):397-409. PubMed ID: 11712871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.
    Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
    Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months].
    D'Argenzio R; Cavallo P; Merante D; Morelli A
    Minerva Endocrinol; 1996 Sep; 21(3):101-10. PubMed ID: 9072666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazepam potentiates the antidiabetic, antistress and anxiolytic activities of metformin in type-2 diabetes mellitus with cooccurring stress in experimental animals.
    Garabadu D; Krishnamurthy S
    Biomed Res Int; 2014; 2014():693074. PubMed ID: 24995322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of an oral antidiabetic combination tablet: design, evaluation and clinical benefits for patients with type 2 diabetes.
    Howlett H; Porte F; Allavoine T; Kuhn T; Nicholson G
    Curr Med Res Opin; 2003; 19(3):218-25. PubMed ID: 12803736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments.
    Lenhard JM; Croom DK; Minnick DT
    Biochem Biophys Res Commun; 2004 Nov; 324(1):92-7. PubMed ID: 15464987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical application of the hypoglycemic agent glibenclamide and changes in blood glucose, plasma insulin (IRI) levels and plasma concentration of glibenclamide in normal rats.
    Yamamoto T; Katakabe K; Akiyoshi K; Kan K; Asano T; Okumura M
    Diabetes Res Clin Pract; 1990 Jan; 8(1):19-22. PubMed ID: 2105197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
    Gudat U; Bungert S; Kemmer F; Heinemann L
    Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nadolol-glibenclamide interaction: relevance to carbohydrate metabolism in hyperglycaemic rats.
    Abdel Aziz AH; Moustafa AM; Abd Ellah MF; el-Mazar MA
    Pharmacol Res; 1996; 34(1-2):11-5. PubMed ID: 8981550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of praziquantel on serum glucose and insulin levels in normal and hyperglycemic rats.
    el-Kashef HA; Salem HA; Said SA; Elmazar MM
    Arzneimittelforschung; 1996 Apr; 46(4):433-5. PubMed ID: 8740094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study.
    Nachum Z; Zafran N; Salim R; Hissin N; Hasanein J; Gam Ze Letova Y; Suleiman A; Yefet E
    Diabetes Care; 2017 Mar; 40(3):332-337. PubMed ID: 28077460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus.
    González-Ortiz M; Guerrero-Romero JF; Violante-Ortiz R; Wacher-Rodarte N; Martínez-Abundis E; Aguilar-Salinas C; Islas-Andrade S; Arechavaleta-Granell R; González-Canudas J; Rodríguez-Morán M; Zavala-Suárez E; Ramos-Zavala MG; Metha R; Revilla-Monsalve C; Beltrán-Jaramillo TJ
    J Diabetes Complications; 2009; 23(6):376-9. PubMed ID: 18849173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
    Rave K; Flesch S; Kühn-Velten WN; Hompesch BC; Heinemann L; Heise T
    Diabetes Metab Res Rev; 2005; 21(5):459-64. PubMed ID: 15915547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo interaction between gliclazide and glibenclamide and insulin on glucose disposal in the rat.
    Tanira MO; Furman BL
    Pharmacol Res; 1999 May; 39(5):349-56. PubMed ID: 10328992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients.
    Raptis AE; Tountas NB; Yalouris AG; Halvatsiotis PG; Raptis SA
    Horm Metab Res; 1996 Feb; 28(2):89-94. PubMed ID: 8867905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycaemic effects of antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic rats.
    Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Shibasaki M
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):560-8. PubMed ID: 18793271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.